BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10973234)

  • 1. Melanocortins and body weight: a tale of two receptors.
    Cummings DE; Schwartz MW
    Nat Genet; 2000 Sep; 26(1):8-9. PubMed ID: 10973234
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.
    Chen AS; Marsh DJ; Trumbauer ME; Frazier EG; Guan XM; Yu H; Rosenblum CI; Vongs A; Feng Y; Cao L; Metzger JM; Strack AM; Camacho RE; Mellin TN; Nunes CN; Min W; Fisher J; Gopal-Truter S; MacIntyre DE; Chen HY; Van der Ploeg LH
    Nat Genet; 2000 Sep; 26(1):97-102. PubMed ID: 10973258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mouse that eats less but gains weight.
    Alfred J
    Nat Rev Genet; 2000 Oct; 1(1):7. PubMed ID: 11262878
    [No Abstract]   [Full Text] [Related]  

  • 5. Mc3 and Mc4 receptors: complementary role in weight control.
    Raffin-Sanson ML; Bertherat J
    Eur J Endocrinol; 2001 Mar; 144(3):207-8. PubMed ID: 11248737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relevance of the melanocortinergic system for body weight regulation].
    Raab M; Hinney A; Grassl W; Remschmidt H; Hebebrand J
    Dtsch Med Wochenschr; 2003 Feb; 128(9):447-52. PubMed ID: 12612858
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat.
    Butler AA; Marks DL; Fan W; Kuhn CM; Bartolome M; Cone RD
    Nat Neurosci; 2001 Jun; 4(6):605-11. PubMed ID: 11369941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice.
    Weide K; Christ N; Moar KM; Arens J; Hinney A; Mercer JG; Eiden S; Schmidt I
    Physiol Genomics; 2003 Mar; 13(1):47-56. PubMed ID: 12644632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective melanocortin 4 receptors in hyperphagia and morbid obesity.
    List JF; Habener JF
    N Engl J Med; 2003 Mar; 348(12):1160-3. PubMed ID: 12646673
    [No Abstract]   [Full Text] [Related]  

  • 10. The alphabet of weight control.
    Friedman JM
    Nature; 1997 Jan; 385(6612):119-20. PubMed ID: 8990109
    [No Abstract]   [Full Text] [Related]  

  • 11. The proof of the pudding is in the eating: editorial focus on "Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4-receptor knockout mice".
    MacIntyre DE; Glueck SB
    Physiol Genomics; 2003 Mar; 13(1):11-4. PubMed ID: 12644629
    [No Abstract]   [Full Text] [Related]  

  • 12. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
    Zemel MB; Shi H
    Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles for melanocortins and leptin in adipose tissue apoptosis and fat deposition.
    Della-Fera MA; Baile CA
    Peptides; 2005 Oct; 26(10):1782-7. PubMed ID: 16002187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To eat or not to eat - how the gut talks to the brain.
    Korner J; Leibel RL
    N Engl J Med; 2003 Sep; 349(10):926-8. PubMed ID: 12954739
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the central melanocortin system in cachexia.
    Marks DL; Ling N; Cone RD
    Cancer Res; 2001 Feb; 61(4):1432-8. PubMed ID: 11245447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New aspects on the melanocortins and their receptors.
    Wikberg JE; Muceniece R; Mandrika I; Prusis P; Lindblom J; Post C; Skottner A
    Pharmacol Res; 2000 Nov; 42(5):393-420. PubMed ID: 11023702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of central melanocortin pathways by fenfluramine.
    Heisler LK; Cowley MA; Tecott LH; Fan W; Low MJ; Smart JL; Rubinstein M; Tatro JB; Marcus JN; Holstege H; Lee CE; Cone RD; Elmquist JK
    Science; 2002 Jul; 297(5581):609-11. PubMed ID: 12142539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
    Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
    J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin.
    Rahmouni K; Haynes WG; Morgan DA; Mark AL
    J Neurosci; 2003 Jul; 23(14):5998-6004. PubMed ID: 12853417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.